Lack of CXC chemokine receptor 3 signaling leads to hypertrophic and hypercellular scarring

American Journal of Pathology

Volumn 176, Issue 4, 2010, Pages 1743-1755

  Yates, Cecelia C ^a,b,c   Krishna, Priya ^a   Whaley, Diana ^b   Bodnar, Richard ^a,b   Turner, Timothy ^c   Wells, Alan ^a,b,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c TUSKEGEE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; COLLAGEN FIBER; COLLAGEN FIBRIL; GELATINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DERMIS; EPIDERMIS; EXTRACELLULAR MATRIX; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERCELLULAR SCARRING; HYPERTROPHIC SCAR; IN VIVO STUDY; INFLAMMATION; KERATINIZATION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCAR FORMATION; SIGNAL TRANSDUCTION; TENSILE STRENGTH; TURNOVER TIME; WILD TYPE; WOUND HEALING;

EID: 77950556076     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090564     Document Type: Article

References (43)

1. Singer AJ, Clark RAF: Cutaneous wound healing. N Engl J Med 1999, 341:738-746
2. Aarabi S, Bhatt KA, Shi Y, Paterno J, Change EI, Loh SA, Holmes JW, Longaker MT, Yee H, Gurtner GC: Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. FASEB J 2007, 21:3250-3261 (Pubitemid 47565543)
3. Machesney M, Tidman N, Waseem A, Kirby L, Leigh I: Activated keratinocytes in the epidermis of hypertrophic scars. Am J Pathol 1998, 152:1133-1141 (Pubitemid 28221864)
4. Satish L, Yager D, Wells A: ELR-negative CXC chemokine IP-9 as a mediator of epidermal-dermal communication during wound repair. J Invest Dermatol 2003, 120:1110-1117
5. Ramos ML, Gragnani A, Ferreira LM: Is there an ideal animal model to study hypertrophic scarring. J Burn Care Res 2008, 29:363-368 (Pubitemid 351498833)
6. Zhu KQ, Carrougher GJ, Gibran NS, Isik FF, Engrav LH: Review of the female Duroc/Yorkshire pig model of human fibroproliferative scarring. Wound Repair Regen 2007, 15:S32-S39
7. Ehrlich HP, Desmouliere A, Diegelmann RF, Cohen IK, Compton CC, Garner WL, Kapanci Y, Gabbiani G: Morphological and immunochemical differences between keloids and hypertrophic scar. Am J Pathol 1994, 145:105-113 (Pubitemid 24217489)
8. Yates CC, Whaley D, Hooda S, Hebda PA, Bodnar RJ, Wells A: Delayed re-epithelialization and basement membrane regeneration after wounding in mice lacking CXCR3. Wound Repair Regen 2009, 17:34-41
9. Yates CC, Whaley D, Kulasekeran P, Hancock WW, Lu B, Bodnar R, Newsome J, Hebda PA, Wells A: Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor. Am J Pathol 2007, 171:484-495 (Pubitemid 47344681)
10. Tensen CP, Flier J, vanderRaaij-Helmer EM, Sampat-Sardjoepersad S, vanderSchors RC, Leurs R, Scheper RJ, Boorsma DM, Willemze R: Human IP-9: a keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). J Invest Dermatol 1999, 112:716-722
11. Luster AD, Greenberg SM, Leder P: The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med 1995, 182:219-231
12. Romagnani P, Lasagni L, Annunziato F, Serio M, Romagnani S: CXC chemokines: the regulatory link between inflammation and angiogenesis. Trends Immunol 2004, 25:201-209 (Pubitemid 38372168)
13. Shiraha H, Glading A, Chou J, Jia Z, Wells A: Activation of m-calpain (calpain II) by epidermal growth factor is limited by PKA phosphorylation of m-calpain. Mol Cell Biol 2002, 22:2716-2727 (Pubitemid 34262992)
14. Bodnar R, Yates C, Wells A: IP-10 blocks VEGF-induced endothelial cell motility and tube formation via inhibition of calpain. Circ Res 2006, 98:617-625
15. Satish L, Blair HC, Glading A, Wells A: IP-9 (CXCL11) induced cell motility in keratinocytes requires calcium flux-dependent activation of μ-calpain. Mol Cell Biol 2005, 25:1922-1941
16. Hancock WW, Lu B, Gao W, Csizmadia V, Faia K, King JA, Smiley ST, Ling M, Gerard NP, Gerard C: Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med 2000, 192:1515-1520
17. Murillas R, Larcher F, Santos M, Ullrich A, Jorcano JL: Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair development and skin structure. EMBO J 1995, 14:5216-5223
18. Yates CC, Whaley D, Yen A, Kulesekaran P, Hebda PA, Wells A: ELR-negative CXC chemokine CXCL11(IP-9/I-TAC) facilitates dermal and epidermal maturation during wound repair. Am J Pathol 2008, 173:643-652
19. Lee JY-Y, Yang C-C, Chao S-C, Wong T-W: Histopathological differential diagnosis of keloid and hypertrophic scar. Am J Dermatopathol 2004, 26:379-384 (Pubitemid 39287358)
20. Clark RAF (Ed): The Molecular Cell Biology of Wound Repair. New York, Plenum Press, 1996, pp 31-36
21. Shao H, Yin X-M, Wells A: Epidermal growth factor protects fibroblasts from apoptosis via PI3 kinase and rac signaling pathways. Wound Repair Regen 2008, 16:551-558 (Pubitemid 352002765)
22. Allen FD, Asnes CF, Chang P, Elson EL, Lauffenburger DA, Wells A: EGF-induced matrix contraction is modulated by calpain. Wound Repair Regen 2002, 10:67-76
23. Akasaka Y, Fujita K, Ishikawa Y, Asuwa N, Inuzuka K, Ishihara M, Ito M, Masuda T, Akishima Y, Zhang L, Ito K, Ishii T: Detection of apoptosis in keloids and a comparative study on apoptosis between keloids, hypertrophic scars, normal healed flat scars, and dermatofibroma. Wound Repair Regen 2001, 9:501-506 (Pubitemid 34266730)
24. Chuong CM, Chen HM: Enhanced expression of neural cell adhesion molecules and tenascin (cytotactin) during wound healing. Am J Pathol 1991, 138:427-440
25. Sible JC, Rettig WJ, Eriksson E, Smith SP, Oliver N: Gene expression of tenascin is altered in normal scars and keloids. Wound Repair Regen 1995, 3:37-48
26. Lim IJ, Phan TT, Bay BH, Qi R, Huynh H, Tan WT, Lee ST, Longaker MT: Fibroblasts cocultured with keloid keratinocytes: normal fibroblasts secrete collagen in a keloid-like manner. Am J Physiol Cell Physiol 2002, 283:C212-C222 (Pubitemid 34670565)
27. Ala-Kokko L, Rintala A, Savolainen ER: Collagen gene expression in keloids: analysis of collagen metabolism and type I, III, IV, and V procollagen mRNAs in keloid tissue and keloid fibroblast cultures. J Invest Dermatol 1987, 89:238-244 (Pubitemid 17126576)
28. Babu M, Wells A: Dermal-epidermal communication in wound healing. Wounds 2001, 13:183-189
29. Singer AJ, McClain SA: Persistent wound infection delays epidermal maturation and increases scarring in thermal burns. Wound Repair Regen 2002, 10:372-377
30. Jinquan T, Jing C, Jacobi HH, Reimert CM, Millner A, Quan S, Hansen JB, Dissing S, Malling HJ, Skov PS, Poulsen LK: CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma. J Immunol 2000, 165:1548-1556 (Pubitemid 30604591)
31. Farber JM: Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 1997, 61:246-257
32. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B: Chemokine receptor specific for IP10 and MIG: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996, 184:963-969 (Pubitemid 26313554)
33. Bodnar RJ, Yates CC, Du X, Wells A: ELR-negative chemokine IP-10/CXCL10 induces dissociation of newly-formed vessels secondary to calpain cleavage of beta3 integrin. J Cell Sci 2009, 122:2064-2077
34. Juhasz I, Murphy GF, Yan HC, Herlyn M, Albelda SM: Regulation of extracellular matrix proteins and integrin cell substratum adhesion receptors on epithelium during cutaneous human wound healing in vivo. Am J Pathol 1993, 143:1458-1469 (Pubitemid 24057116)
35. Tran KT, Griffith LG, Wells A: Extracellular matrix signaling through growth factor receptors during wound healing. Wound Repair Regen 2004, 12:262-268
36. Iyer AKV, Tran KT, Griffith L, Wells A: Cell surface restriction of EGFR by a Tenascin cytotactin-encoded EGF-like repeat is preferential for motility-related signaling. J Cell Physiol 2007, 214:504-512 (Pubitemid 350309007)
37. Tang Z, Zhang Z, Zheng Y, Corbley MJ, Tong T: Cell aging of human diploid fibroblasts is associated with changes in responsiveness to epidermal growth factor and changes in HER-2 expression. Mech Ageing Dev 1994, 73:57-67 (Pubitemid 24070934)
38. Shiraha H, Gupta K, Drabik KA, Wells A: Aging fibroblasts present reduced epidermal growth factor (EGF) responsiveness due to preferential loss of EGF receptors. J Biol Chem 2000, 275:19343-19351 (Pubitemid 30422908)
39. Chamberlain G, Fox J, Ashton B, Middleton J: Mesenchymal stem cells: their phenotype, differentiation capacity, immunological feature, and potential for homing. Stem Cells 2007, 25:2739-2749 (Pubitemid 350127858)
40. Opalenik SR, Davidson JM: Fibroblast differentiation of bone marrow-derived cells during wound repair. FASEB J 2005, 19:1561-1563 (Pubitemid 41279031)
41. Garmy-Susini B, Varner JA: Circulating endothelial progrenitor cells. Br J Cancer 2005, 93:855-858
42. Datta D, Contreras AG, Grimm M, Waage-Gasser AM, Briscoe DM, Pal S: Calcineurin inhibitors mediate CXCR3 splice variant expression and mediate renal cancer progression. J Am Soc Nephrol 2008, 19:2437-2446
43. Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG, Nedeau A, Thom SR, Velazquez OC: Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 2007, 117:1249-1259 (Pubitemid 46718413)